deltatrials
Completed PHASE1 NCT00108511

Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides

Effect of Gemfibrozil on Serum GPI Phospholipase D and Triglycerides

Sponsor: US Department of Veterans Affairs

Conditions Hypertriglyceridemia
Interventions Gemfibrozil
Updated 6 times since 2017 Last updated: Jan 20, 2009 Started: Oct 31, 2004 Completion: Sep 30, 2007

A PHASE1 clinical study on Hypertriglyceridemia, this trial is completed. The trial is conducted by US Department of Veterans Affairs and has accumulated 6 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Aug 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • US Department of Veterans Affairs
Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Indianapolis, United States